FLAVOUR Study: FLow profiles And postoperative VasOplegia after continUous-flow left ventriculaR assist device implantation

  • BJ Kersten
  • , L Numan
  • , MM van der Schoot
  • , M de Jong
  • , F Ramjankhan
  • , E Aarts
  • , MIFJ Oerlemans
  • , LW van Laake
  • , EEC de Waal

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Abstract: This study aims to associate the incidence of postoperative vasoplegia and short-term survival to the implantation of various left ventricular assist devices differing in hemocompatibility and flow profiles. The overall incidence of vasoplegia was 25.3% (73/289 patients) and 30.3% (37/122), 25.0% (18/72), and 18.9% (18/95) in the axial flow (AXF), centrifugal flow (CF), and centrifugal flow with artificial pulse (CFAP) group, respectively. Vasoplegia was associated with longer intensive care (ICU) and hospital length of stay (LOS) and mortality. ICU and in-hospital LOS and 1-year mortality were the lowest in the CFAP group. Post hoc analysis resulted in a p-value of 0.43 between AXF and CF; 0.35 between CF and CFAP; and 0.06 between AXF and CFAP. Although there is a trend in diminished incidence of vasoplegia, pooled logistic regression using flow profile and variables that remained after feature selection showed that flow profile was not an independent predictor for postoperative vasoplegia. Graphical Abstract: (Figure presented.)

Original languageEnglish
Pages (from-to)252-264
Number of pages13
JournalJournal of Cardiovascular Translational Research
Volume17
Issue number2
Early online date1 Feb 2024
DOIs
Publication statusPublished - 2024

Bibliographical note

Publisher Copyright:
© The Author(s) 2024.

Keywords

  • Axial flow
  • Cardiac vasoplegia syndrome
  • Centrifugal flow
  • Centrifugal flow with artificial pulse
  • Continuous-flow left ventricular assist device
  • Flow profile
  • Morbidity
  • Mortality
  • Outcomes

Fingerprint

Dive into the research topics of 'FLAVOUR Study: FLow profiles And postoperative VasOplegia after continUous-flow left ventriculaR assist device implantation'. Together they form a unique fingerprint.

Cite this